Pharmaceutical interventions in chemotherapy prescriptions in a public hospital in the Federal District
DOI:
https://doi.org/10.55892/jrg.v8i18.2136Keywords:
Pharmaceutical care, Antineoplastic agents, Pharmacovigilance, Medical OncologyAbstract
Prescription errors are characterized by mistakes that occur during the writing of the prescription. Patients using antineoplasic drugs are susceptible to more griveous errors, due to the intrinsic characteristics of these drugs. Therefore, pharmacists play a crucial role in identifying errors in prescription analysis. The interventions performed and the drugs most involved in adjustments were observed between 2022-2023, totaling 24 months. In total, 8,712 prescriptions were reviewed, of which 1,307 required intervention, corresponding to a total of 1,728 prescription adjustments. With a ratio of 1.32 interventions per prescription. The data found do not differ from other findings in similar studies carried out in Brazil, but demonstrate that oncology is one of the areas with the greatest potential for prescription adjustments.
Downloads
References
Tariq RA, Vashisht R, Sinha A, Scherbak Y. Medication Dispensing Errors and Prevention. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK519065/
Abreu FG. Erros de medicação: avaliação da prescrição e percepção dos profissionais de enfermagem [Trabalho de Conclusão de Curso]. Brasília (DF): Universidade de Brasília; 2013.
Instituto para Práticas Seguras no Uso de Medicamentos. PREVENÇÃO DE ERROS DE PRESCRIÇÃO. Bol ISMP [Internet]. Mar 2021 [citado 20 maio 2025];10(2). Disponível em: https://www.ismp-brasil.org/site/wp-content/uploads/2021/03/Boletim-ISMP-Prevencao-Erros-Prescricao.pdf
Ranchon F, Salles G, Späth HM, Schwiertz V, Vantard N, Parat S, Broussais F, et al. Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer. 2011 Nov 8; 11:478.
Schwappach DLB, Wernli M. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. European Journal of Cancer Care. 2010 May;19(3):285–92.
Weiss BD, Scott M, Demmel K, Kotagal UR, Perentesis JP, Walsh KE. Significant and Sustained Reduction in Chemotherapy Errors Through Improvement Science. J Oncol Pract. 2017 Apr;13(4):e329-e336.
Fernandes RM, Marsola APZC, Arado GM, Andrucioli FS, Oliveira TT, Ungari AQ, et al. Intervenções farmacêuticas em prescrições ambulatoriais de medicamentos antineoplásicos no hospital das clínicas de Ribeirão Preto. Revista qualidade HC. USP. 2012 dez. 3.
Brasil. Portaria GM/MS nº 2.203, de 5 de novembro de 1996, Diário Oficial da União, 6 nov 1996; Seção 1(216).
MINISTÉRIO DA SAÚDE (Brasil). Secretaria de Atenção Especializada à Saúde. Departamento de Regulação, Avaliação e Controle. Coordenação-Geral de Gestão dos Sistemas de Informações em Saúde. SIA/SUS: Sistema de Informações Ambulatoriais: Oncologia: Manual de Bases Técnicas. 30ª ed. Brasília, DF: Ministério da Saúde, 2022.
Kloth DD. Prevention of Chemotherapy Medication Errors. Journal of Pharmacy Practice. 2002 Feb;15(1):17–31.
Dinning C, Branowicki P, O’Neill JB, Marino BL, Billett A. Chemotherapy Error Reduction: A Multidisciplinary Approach to Create Templated Order Sets. Journal of Pediatric Oncology Nursing. 2005 Jan;22(1):20–30.
Hess E, Palmer SE, Stivers A, Amerine LB. Impact of an electronic health record transition on chemotherapy error reporting. J Oncol Pharm Pract. 2020 Jun;26(4):787-793.
Duarte NC, Barbosa CR, Tavares MG, Dias LP, Souza RN, Moriel P. Clinical oncology pharmacist: Effective contribution to patient safety. Journal of Oncology Pharmacy Practice. 2018 Oct 22;25(7):1665–74.
Silva GT, Pereira TLF, Gomes TMS. Perfil de intervenções farmacêuticas em prescrições de protocolos antineoplásicos e aceitação médica: um trabalho multiprofissional na segurança do paciente. Medicina: Longe dos holofotes, perto das pessoas 2021 Oct 8(3);146–55.
da Rocha C, Carlotto J, Zanis Neto J. Analysis of the interventions in antineoplastic therapy by a clinical pharmacy service at a tertiary hospital in Brazil. J Oncol Pharm Pract. 2022 Jul;28(5):1049-1055.
